Loss or weakening of AKT signaling would result in transcriptional rearrangement of differentiated cytotoxic T lymphocytes, transforming effector cells into memory cells to enhance the anti-tumor effects in the immune system (40, 41). The gene discussed is AKT1; the disease is neoplasm.